Amanda
Feilding
Director
of The Beckley Foundation
Amanda
Feilding’s Talk at the Psychedelic Science
in the 21st Century Conference in San Jose
Science
of the Mind — POSTED
BY Amanda Feilding on April 25, 2010 at 2:24 pm
It’s
great to be here today, with so many companeros, on this eve of the 16th
of April, the day 67 years ago, when Albert Hoffman accidentally experienced
his first LSD-trip, which launched the thousand ships on which we now sail.
I
set up the Beckley Foundation in 1998 for the purpose of scientifically
studying consciousness and its altered states.
Growing
up in an isolated but magical garden on the edge of a marsh in England,
I enjoyed several childhood mystical experiences, from which I developed
a passionate interest in mysticism, the Sufis and Bhuddism. After my first
psychedelic experience with LSD in 1965, I became fascinated by the scientific
question: what physiological processes underlie the alteration of consciousness
brought about by this miraculous substance? In particular, my explorations
led me to wonder whether one of LSD’s principal actions was to increase
the blood supply to the brain capillaries, thereby providing extra glucose
and oxygen to the brain cells, accelerating brain metabolism, which may
in turn be the cause of those experiences that are shared by both psychedelic
and mystical states of consciousness. (cont'd)
Amanda
Feilding
is
the co-founder of brainwaving.com and Director of The Beckley
Foundation, a charitable trust that was set up to investigate consciousness
and its changing states from a multidisciplinary perspective.
Through
its Science Programme the Foundation initiates, develops and conducts world-class
research that will improve not only our scientific understanding of consciousness,
but also provide practical information to help optimize health and well
being.
The
Foundation is working at the frontiers of the renaissance of psychedelic
research. It is also undertaking pioneering research into cerebral circulation
and its impact on the aging process, including possible ways to counteract
some of its debilitating effects.
Collaborative
work initiated by the Foundation has brought about not only the first research
into LSD with human participants since prohibition, but also the first
explanation of the physiology underlying the beneficial effects of the
ancient procedure of trepanation. In addition to the Science Programme,
the Beckley Foundation conducts a Drug Policy Programme which is dedicated
to providing a rigorous, independent review of global drug policy.
The
Foundation's overarching aim is to reduce the harms associated with both
the misuse of drugs and the policies that aim to control them. To this
end, the Foundation commissions reports, alongside organising international
seminars which promote informed debate among leading experts from around
the world on the many issues surrounding drugs.
The
intention of the Foundation is to help develop policies that are evidence-based
and rational, rather than those that are ineffectual, due to being rooted
in unsubstantiated ideology. |
|